TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7698050

Group type: EXPERIMENTAL
Intervention: Topical human recombinant basic fibroblast growth factor (bFGF) applied daily for 6 weeks, then twice a week for 12 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo applied daily for 6 weeks, then twice a week for 12 weeks
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: bFGF
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 2793774

Group type: EXPERIMENTAL
Intervention: Experimental intervention (training in job seeking with a problem-solving process emphasizing inoculation against setbacks and positive social reinforcement)
Number of subjects: 928

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 928
Study: 860200

Group type: COMPARATOR
Intervention: Ringer's lactate (RLS)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Ringer's lactate with albumin (ALB)
Number of subjects: 141
Study: 31834588

Group type: EXPERIMENTAL
Intervention: Training Executive, Attention and Motor Skills (TEAMS)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Parent education and support (comparison intervention)
Number of subjects: 52
Study: 30880441

Group type: EXPERIMENTAL
Intervention: Endovascular ultrasound renal denervation (RDN)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Endovascular ultrasound renal denervation (RDN) and Sham procedure
Number of subjects: 146
Study: 27530106

Group type: EXPERIMENTAL
Intervention: Directives on opioid prescribing released by the Veterans Health Administration (VHA) or the Food and Drug Administration (FDA)
Number of subjects: 32200000
Study: 25992918

Group type: EXPERIMENTAL
Intervention: Low-dose prednisone (15 mg/d)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Medium-dose prednisone (30 mg/d)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: High-dose prednisone (60 mg/d)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard HF care alone
Number of subjects: 38
Study: 23364407

Group type: EXPERIMENTAL
Intervention: EMLA
Number of subjects: 267

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 267
Study: 20661580

Group type: EXPERIMENTAL
Intervention: Letrozole for 2 months
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Triptorelin for 2 months
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 144
Study: 19565728

Group type: EXPERIMENTAL
Intervention: Compound PuHuang Granules
Number of subjects: 328

Group type: COMPARATOR
Intervention: NaoXueShuan Tablets
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 328
Study: 16395298

Group type: EXPERIMENTAL
Intervention: Modafinil 200 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Modafinil 400 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 15115949

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Zuclopenthixol
Number of subjects: 25

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 25
Study: 11128820

Group type: EXPERIMENTAL
Intervention: Brief acupuncture
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 50
Study: 9106572

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 20
Study: 1437435

Group type: EXPERIMENTAL
Intervention: Nebulized albuterol (0.15 mg/kg per dose) and ipratropium bromide (250 micrograms per dose)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Nebulized albuterol and normal saline (placebo)
Number of subjects: 69
Study: 3083920

Group type: EXPERIMENTAL
Intervention: Surgeries booked at 10 minute intervals
Number of subjects: 623

Group type: COMPARATOR
Intervention: Surgeries booked at 7.5 minute intervals
Number of subjects: 623

Group type: COMPARATOR
Intervention: Surgeries booked at 5 minute intervals
Number of subjects: 623
Study: 29849557

Group type: EXPERIMENTAL
Intervention: Simple mechanical tactile stimulation (MS)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Lateral mechanical tactile stimulation (MS)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Rubbing mechanical tactile stimulation (MS)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Vertical mechanical tactile stimulation (MS)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Random mechanical tactile stimulation (MS)
Number of subjects: 19
Study: 26646751

Group type: EXPERIMENTAL
Intervention: Higher dose of hydrocortisone (0.4‐0.6 mg/kg body weight/day)
Number of subjects: 47
Study: 24892882

Group type: EXPERIMENTAL
Intervention: Conversation-based training program
Number of subjects: 91

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 91
Study: 22149763

Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix (ADM) hydrated in recombinant human platelet-derived growth factor (rhPDGF)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Acellular dermal matrix (ADM) hydrated in sterile saline (control)
Number of subjects: 17
Study: 19650962

Group type: EXPERIMENTAL
Intervention: Free healthy school lunch served to pupils over 4 months (January to May 2007)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Free healthy school lunch
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control schools (no free lunch)
Number of subjects: 150
Study: 18355797

Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy (NPWT) using the Vacuum-Assisted Closure (V.A.C.) system
Number of subjects: 162

Group type: COMPARATOR
Intervention: Standard moist wound therapy (MWT)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy (NPWT)
Number of subjects: 162
Study: 16043008

Group type: EXPERIMENTAL
Intervention: Depressed group
Number of subjects: 200

Group type: COMPARATOR
Intervention: Non-depressed group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Depressed participants
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Participants taking prescribed medications
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Self-care pain management strategies
Number of subjects: 200
Study: 12390105

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 30 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 10 mg
Number of subjects: 9
Study: 10090549

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Medical treatment
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Age at entry < 3 years
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Age at entry > 3 years
Number of subjects: 236
Study: 7800005

Group type: EXPERIMENTAL
Intervention: Antibacterial treatment (120 mg of bismuth subcitrate, 500 mg of tetracycline, and 400 mg of metronidazole, each given orally four times a day for one week)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Antibacterial treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Omeprazole (20 mg orally per day for four weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Omeprazole
Number of subjects: 100
Study: 2129915

Group type: EXPERIMENTAL
Intervention: Direct placement composite resin (Ful‐fil)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Direct composite resin inlay (Brillant D.I.)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Direct composite resin inlay (Ful‐fil)
Number of subjects: 36
Study: 119526

Group type: EXPERIMENTAL
Intervention: Pentaerythritol trinitrate (PTN)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Nitroglycerine (NG)
Number of subjects: 28
Study: 30948276

Group type: EXPERIMENTAL
Intervention: RB-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone + Bortezomib 1.3 mg/m2 intravenously or 1.6 mg/m2 subcutaneously on days 1 and 8 for cycles two to six)
Number of subjects: 918

Group type: COMPARATOR
Intervention: R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone)
Number of subjects: 918

Group type: EXPERIMENTAL
Intervention: RB-CHOP
Number of subjects: 918

Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 918
Study: 30374690

Group type: EXPERIMENTAL
Intervention: List of important questions provided to relatives immediately after randomization.
Number of subjects: 394

Group type: COMPARATOR
Intervention: Standard care (control group) without the list of questions.
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Intervention group (list of questions)
Number of subjects: 394

Group type: COMPARATOR
Intervention: Control group (no list of questions)
Number of subjects: 394
Study: 26894333

Group type: EXPERIMENTAL
Intervention: Combined SBRT and ICBT
Number of subjects: 40
Study: 25127655

Group type: EXPERIMENTAL
Intervention: Reduced-dose warfarin for 3-6 days aiming for INR < 1.7
Number of subjects: 171

Group type: COMPARATOR
Intervention: Interrupted warfarin for 5 days with LMWH bridging for 2.5 days
Number of subjects: 171
Study: 22622649

Group type: EXPERIMENTAL
Intervention: Levosimendan (0.1 μg/kg/min for 24 hours)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Milrinone (0.5 μg/kg/min for 24 hours)
Number of subjects: 40
Study: 19922961

Group type: EXPERIMENTAL
Intervention: RSG (rosiglitazone 8 mg/d)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: EX (exercise training)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: RSG + EX (rosiglitazone 8 mg/d plus exercise training)
Number of subjects: 100

Group type: COMPARATOR
Intervention: CO (maintenance of habitual activities)
Number of subjects: 100
Study: 17672962

Group type: EXPERIMENTAL
Intervention: Yunnan Baiyao (500 mg four times daily for 3 days before surgery)
Number of subjects: 203
Study: 15615872

Group type: EXPERIMENTAL
Intervention: Zinc gluconate (140 mg/day; n=26)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (lactose; n=24)
Number of subjects: 50
Study: 14601481

Group type: EXPERIMENTAL
Intervention: Osteopenia (n = 27)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Osteoporosis (n = 25)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Controls (n = 29)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Osteopenia and Osteoporosis (n = 52 combined)
Number of subjects: 81
Study: 9698950

Group type: EXPERIMENTAL
Intervention: hyperbaric lidocaine 50 mg/ml diluted with CSF 1:1 (Group L)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: hyperbaric mepivacaine 40 mg/ml (Group M)
Number of subjects: 90

Group type: COMPARATOR
Intervention: hyperbaric bupivacaine 5 mg/ml (Group B)
Number of subjects: 90
Study: 8681269

Group type: EXPERIMENTAL
Intervention: Bright light therapy using a fluorescent light box (2500 lux for 2 hours per day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bright light therapy using a fluorescent light box (10,000 lux for 30 minutes)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Light visors and other head‐mounted devices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: d‐fenfluramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dawn simulation
Number of subjects: 0
Study: 2091459

Group type: EXPERIMENTAL
Intervention: Assertive Community Treatment (ACT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Drop-in (DI) center
Number of subjects: 82
Study: 158570

Group type: EXPERIMENTAL
Intervention: tretinoin lotion 0.05% applied in the morning and benzoyl peroxide 5% and 10% applied at night
Number of subjects: 250
Study: 31833175

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ticagrelor and Clopidogrel
Number of subjects: 60
Study: 31127955

Group type: EXPERIMENTAL
Intervention: 2Shape system followed by MM1500
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Reciproc system followed by MM1500
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sonic activation with MM1500 in the first group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sonic activation with Eddy in the second group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sonic activation with MM1500 in the third group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sonic activation with Eddy in the fourth group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison of all groups
Number of subjects: 40
Study: 28463827

Group type: EXPERIMENTAL
Intervention: Taurolidine lock solution
Number of subjects: 163

Group type: COMPARATOR
Intervention: Standard saline solution (Control)
Number of subjects: 163
Study: 26110667

Group type: EXPERIMENTAL
Intervention: Mammography and MR imaging
Number of subjects: 36185

Group type: COMPARATOR
Intervention: Mammography
Number of subjects: 36185
Study: 23894905

Group type: EXPERIMENTAL
Intervention: Educational programme for parents (3 educational sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 0
Study: 22779096

Group type: EXPERIMENTAL
Intervention: Adapalene 0.1% lotion
Number of subjects: 144

Group type: COMPARATOR
Intervention: Adapalene 0.1% cream
Number of subjects: 144
Study: 19958063

Group type: EXPERIMENTAL
Intervention: Educational outreach visits for reducing selected antibiotics (14 practices)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Educational outreach visits for improving antidepressant prescribing (14 practices)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (14 practices not receiving educational outreach)
Number of subjects: 28
Study: 17944686

Group type: EXPERIMENTAL
Intervention: lopinavir/saquinavir/ritonavir (LPV/SQV/r; 400/1000/100 mg bid)
Number of subjects: 64

Group type: COMPARATOR
Intervention: indinavir/ritonavir (IDV/r; 800/100 mg bid) plus two NRTIs
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: lopinavir/saquinavir/ritonavir (LPV/SQV/r)
Number of subjects: 64

Group type: COMPARATOR
Intervention: indinavir/ritonavir (IDV/r) plus two NRTIs
Number of subjects: 64
Study: 15356029

Group type: EXPERIMENTAL
Intervention: Metformin (425 mg/d) for 6 months in prepubertal girls
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg/d) for 12 months in postpubertal girls
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (untreated) in prepubertal girls
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (untreated) in postpubertal girls
Number of subjects: 57
Study: 11308399

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Progressive Muscle Relaxation Training (RT)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo Treatment
Number of subjects: 75
Study: 9401591

Group type: EXPERIMENTAL
Intervention: Ubiquinone-10 (Q10) supplementation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 8323306

Group type: EXPERIMENTAL
Intervention: Hydroactive dressing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional therapy (bacitracin plus Band‐Aid)
Number of subjects: 50
Study: 3479490

Group type: EXPERIMENTAL
Intervention: Sealed composite restoration placed over carious lesion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional outline-form (unsealed) amalgam restoration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ultraconservative sealed amalgam restoration
Number of subjects: 0
Study: 31176727

Group type: EXPERIMENTAL
Intervention: Post-encoding stress (cold pressor for 3 min)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control task (warm water for 3 min)
Number of subjects: 80
Study: 28700805

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (50 or 70 mg)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 418

Group type: COMPARATOR
Intervention: Lisdexamfetamine vs Placebo
Number of subjects: 418
Study: 26525419

Group type: EXPERIMENTAL
Intervention: Integrated COPD disease management programme (RECODE)
Number of subjects: 1086

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1086
Study: 24136905

Group type: EXPERIMENTAL
Intervention: Calorie labeling policy in Philadelphia
Number of subjects: 0
Study: 21455808

Group type: EXPERIMENTAL
Intervention: Saxophone-shaped backstrap electrode for vagal stimulation (16 NaR)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cylindrical and rigid electrode (14 NaR)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both electrodes
Number of subjects: 24
Study: 17851460

Group type: EXPERIMENTAL
Intervention: Lactobacillus helveticus fermented milk
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (artificially acidified milk)
Number of subjects: 29
Study: 16473558

Group type: EXPERIMENTAL
Intervention: Extended-release divalproex sodium (divalproex-ER) every 12 hours (q12h)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Once-daily divalproex-ER
Number of subjects: 24
Study: 15246129

Group type: EXPERIMENTAL
Intervention: Interactive group sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Program mainly by mail
Number of subjects: 0
Study: 10885442

Group type: EXPERIMENTAL
Intervention: Hypericum oil (hypericin 110 microg/mL)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Hypericum ointment (hypericin 30 microg/mL)
Number of subjects: 16
Study: 8866087

Group type: EXPERIMENTAL
Intervention: Removal of the nasogastric tube upon tracheal extubation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Retention of the nasogastric tube until the passage of flatus
Number of subjects: 80
Study: 1468386

Group type: EXPERIMENTAL
Intervention: Morphine (group M) - 50 micrograms/kg per h, increased to 100 micrograms/kg per h if needed
Number of subjects: 95

Group type: COMPARATOR
Intervention: Pancuronium (group P) - 100 micrograms/kg as required
Number of subjects: 95

Group type: COMPARATOR
Intervention: Morphine with Pancuronium (group M+P)
Number of subjects: 95
Study: 6331136

Group type: COMPARATOR
Intervention: 40 mg purified brain gangliosides for six months
Number of subjects: 40
Study: 30976851

Group type: EXPERIMENTAL
Intervention: Metformin (2000 mg/day, n=12, MET group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Metformin (2000 mg/day, n=12, CONT group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (n=12, PLA group)
Number of subjects: 24
Study: 29991403

Group type: EXPERIMENTAL
Intervention: Lidocaine with kanamycin (KM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Kanamycin (KM) without lidocaine
Number of subjects: 20
Study: 27812621

Group type: EXPERIMENTAL
Intervention: Continuous rotation
Number of subjects: 56

Group type: COMPARATOR
Intervention: 360° CCW ‐ 30° CW
Number of subjects: 56

Group type: COMPARATOR
Intervention: 270° CCW ‐ 30° CW
Number of subjects: 56

Group type: COMPARATOR
Intervention: 150° CCW ‐ 30° CW
Number of subjects: 56
Study: 25033565

Group type: EXPERIMENTAL
Intervention: Tianeptine (administered for three days)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Physiological saline (administered for three days)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Imipramine (sub-chronic administration for 6 days)
Number of subjects: 2
Study: 22423611

Group type: EXPERIMENTAL
Intervention: IPTi-SP (sulphadoxine-pyrimethamine)
Number of subjects: 5882
Study: 20417447

Group type: EXPERIMENTAL
Intervention: rosuvastatin 20mg
Number of subjects: 753

Group type: COMPARATOR
Intervention: atorvastatin 80mg
Number of subjects: 753
Study: 17021587

Group type: EXPERIMENTAL
Intervention: High-frequency transcutaneous peripheral nerve stimulation (HF-TPNS) for 10 minutes
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control session (no stimulation)
Number of subjects: 18
Study: 16152757

Group type: EXPERIMENTAL
Intervention: IFN-alpha 3 MIU subcutaneously three times a week plus 100 mg MMPD (every 8 h) for 4 weeks
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: IFN-alpha 3 MIU subcutaneously three times a week plus 300 mg MMPD (every 8 h) for 4 weeks
Number of subjects: 54

Group type: COMPARATOR
Intervention: IFN-alpha 3 MIU subcutaneously three times a week alone
Number of subjects: 54
Study: 11966932

Group type: EXPERIMENTAL
Intervention: Amoxycillin (250 mg) and Metronidazole (200 mg) (AM)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Lactate capsules and Metronidazole (PM)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Amoxycillin and Calcium Lactate tablets (AP)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Lactate and Calcium Lactate (PP)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Amoxycillin (AM)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: PM
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: AP
Number of subjects: 66

Group type: COMPARATOR
Intervention: PP
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: AM
Number of subjects: 66
Study: 10424912

Group type: EXPERIMENTAL
Intervention: Vigorous oral hydration (20 mL/kg)
Number of subjects: 35
Study: 7593492

Group type: EXPERIMENTAL
Intervention: Serum IGF-I concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follicular IGF-I concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peripheral circulation IGF-I concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ovarian circulation IGF-I concentrations
Number of subjects: 0
Study: 1602947

Group type: EXPERIMENTAL
Intervention: High potency multivitamin-mineral supplement
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 6147790

Group type: EXPERIMENTAL
Intervention: Febarbamat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pipamperon
Number of subjects: 0
Study: 30825407

Group type: EXPERIMENTAL
Intervention: FocalPoint GS (FPGS) No Further Review (NFR)
Number of subjects: 45317

Group type: COMPARATOR
Intervention: Manual screening
Number of subjects: 45317
Study: 29288035

Group type: EXPERIMENTAL
Intervention: V3 CRT (implantation of an additional LV lead; n = 43)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control (no change; n = 41)
Number of subjects: 84
Study: 26670986

Group type: EXPERIMENTAL
Intervention: Daily changing load (DCL)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Constant load (CL)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Increasing load (IL)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Decreasing load (DL)
Number of subjects: 200
Study: 23584298

Group type: EXPERIMENTAL
Intervention: vandetanib
Number of subjects: 255